Q4 2021 Lantern Pharma Inc. Earnings Call Transcript
Good afternoon, everybody, and welcome to the Lantern Pharma Fourth Quarter and Fiscal Year 2021 Earnings Call. (Operator Instructions) I am Nicole Leber with Investor Relations at Lantern Pharma, and I will be your host for today's call. I will be joined by CEO and President, Panna Sharma; CFO, David Margrave; and CSO, Kishor Bhatia.
We issued a press release after the market closed today summarizing our financial results and progress across the company for the fourth quarter and fiscal year 2021 and a copy of this release is available through our website at lanternpharma.com and where you can also find a link to the slides that management will be referencing for today. Following the safe harbor statement, Panna will provide an overview of Lantern Pharma's operational highlights, after which David will discuss our financial results, which will be followed by Dr. Bhatia, who will provide an update on our development programs. Finally, Panna will offer some concluding comments and then we'll open the call to the Q&A.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |